http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4199585-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d8c378cd7579a3ca5e98166edd5c9fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
filingDate 1978-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1980-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9114ff576e4d824c34ac62ec5dc716d4
publicationDate 1980-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4199585-A
titleOfInvention Method and composition for the therapy of cerebral circulatory diseases
abstract The invention relates to a method and a therapeutic composition for the treatment of cerebral circulatory diseases by administration of vincamine as the active ingredient wherein particular hematic levels are ensured in order to maintain the therapeutic action. More particularly, delayed-release compositions are specially provided.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7052706-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003077324-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006204573-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8545882-B2
priorityDate 1977-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233670981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226513188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454211853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448718630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10953859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136043617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165895

Total number of triples: 39.